In 2024, GlycoNet signed collaborative agreements with three different organizations.
Tag: GlycoNet
GlycoNet and partners invest $12 million in Canadian glycomics research to advance health and agriculture
Twenty-one projects receive funding to develop new therapeutics, tools and solutions by uncovering the roles of biological sugars in health and disease.
GlycoNet Investigator named Tier 2 Canadian Research Chair
Congratulations to Dr. Chantelle Cappiciotti on being recognized for pioneering work in glycan research by the CRC Program.
GlycoNet community members honoured at 2024 ASTech Awards
Congratulations to GlycoNet startup PanTHERA CryoSolutions and GlycoNet researcher Lara Mahal on being recipients of the 2024 ASTech Awards.
Harnessing the power of carbohydrates to improve our health
A better understanding of complex molecules called glycans will bring us closer to disease treatments and innovative solutions to health challenges, say leading researchers.
GlycoNet announces two new members on the Board of Directors
Drs. Kaley Wilson and Elizabeth Nanak bring their insight to GlycoNet’s Board of Directors
GlycoNet Board Member receives Professional Achievement Award
Congratulations to Dr. Nils Petersen on receiving the Professional Achievement Award by the Western University Alumni Association.
GlycoNet startup PanTHERA CryoSolutions receives 2024 Technology Innovation Award
Congratulations to the PanTHERA Cryosolutions team on receiving the 2024 Technology Innovation Award.
Breaking boundaries in organ transplantation with 21st-century glycomics
GlycoNet investigators have developed a new diagnostic test that will advance organ transplantation and enable more transplants across blood type barriers, saving more lives.
GlycoNet and CQDM collaborate to boost drug discovery and develop new health solutions for Canadians
Under a new agreement, GlycoNet and CQDM will explore opportunities together to develop carbohydrate-based tools, technologies and therapeutics that improve health.